Revelation Biosciences Inc (NASDAQ:REVB) price on Thursday, July 03, fall -1.31% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.76.
A look at the stock’s price movement, the close in the last trading session was $0.77, moving within a range at $0.76 and $0.8. The beta value (5-Year monthly) was -0.089. Turning to its 52-week performance, $56.00 and $0.70 were the 52-week high and 52-week low respectively. Overall, REVB moved -15.62% over the past month.
Revelation Biosciences Inc’s market cap currently stands at around $1.54 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-08.
Turning to the stock’s technical picture we see that short term indicators suggest on average that REVB is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend REVB as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
REVB’s current price about -5.61% and -58.70% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 28.30, while 7-day volatility ratio is 10.13% and 8.80% in the 30-day chart. Further, Revelation Biosciences Inc (REVB) has a beta value of -0.09.
If we refocus on Revelation Biosciences Inc (NASDAQ:REVB), historical trading data shows that trading volumes averaged 0.52 over the past 10 days and 1.09 million over the past 3 months. The company’s latest data on shares outstanding shows there are 2.03 million shares.
The 0.03% of Revelation Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 1.89% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.15 million on 2025-06-13, giving us a short ratio of 0.06. The data shows that as of 2025-06-13 short interest in Revelation Biosciences Inc (REVB) stood at 332.0 of shares outstanding, with shares short rising to 41764.0 registered in 2025-05-15. Current price change has pushed the stock -97.46% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the REVB stock continues to rise going into the next quarter.
